sante cabinets

How do these four analyses build a market view?

Each window links an official source to the entities involved, the attributes that change the decision, the evidence required and the acquisition channels to test. The sector page moves from regulatory signal to opportunity portfolio without confusing developed potential with confidential results.

Does your market present a comparable window?

The eligibility report dates and quantifies it, then tests whether it deserves action.

Where is the next buying decision taking shape?

An app can be recognised as a medical device, address a specific indication and remain absent from everyday clinical work. That gap is commercial, operational and clinical at once. On 1 July 2026, compulsory health insurance began covering an interactive digital cognitive behavioural therapy application for certain forms of depression. Prescribing is restricted to specified professionals, use is limited to 90 days and the item is under evaluation until the end of 2026. A reimbursement code opens a door; it does not train prescribers, organise patient information or show that the therapy suits every situation. This insight follows regulatory eligibility, medical decision, activation and follow-up . It identifies a first purchase: a prescriber-activation study in one territory, paired with a practice integration protocol. It explains how to measure adoption without turning depression into an advertising segment or promising a therapeutic outcome. Potential exists because eligible prescribers are identifiable; its value depends on cautious implementation, support and separate evidence at every stage. General analysis updated on 7 August 2026. It does not replace a prescription, clinical judgement, reimbursement decision or surveillance decision.

Turn a market change into qualified demand.

On 1 January 2026, Swiss outpatient billing adopted a new language. A service is now billed either under TARDOC or through an outpatient flat rate; the two approaches cannot be combined. For a medical practice or centre, the risk is not limited to selecting the wrong code. It emerges when the appointment book, clinical documentation, consumables, software and invoice describe five different versions of the same patient encounter. This insight follows a care pathway from booking through to invoice control. It explains how to select services for review, measure discrepancies without disrupting operations and turn corrections into a quality routine. The proposed first purchase is neither a revenue promise nor a general tariff approval: it is a targeted diagnostic covering a small number of common pathways. For a specialist partner, this is a practical opportunity because the new system is operating, accountable decision-makers can be identified, and cost-neutrality monitoring will continue until at least 2028. Updated on 7 August 2026. This does not replace the official tariff structures, applicable agreements or a decision by tariff partners or authorities.

4 readings · sante cabinets

Does your market present a comparable window?

The eligibility report dates and quantifies it, then tests whether it deserves action.